The recent revival of interest in microbial fermentation for the production of biologics can be attributed to several key factors. Notably, advancements in biochemistry and a deeper understanding of glycosylation processes have illuminated scenarios where glycosylation may be undesirable. This evolving knowledge has paved the way for innovative approaches in biologics manufacturing. The emergence of new protein formats and scaffolds that align seamlessly with microbial fermentation technologies has further fueled this trend. These novel structures not only enhance the efficiency of production but also extend the applicability of microbial systems to the generation of DNA plasmids. Through successful optimization efforts, it is now possible to develop scalable fermentation processes that achieve not only high titers and productivity but also exhibit remarkable stability and reliability.
Under the right circumstances, this approach presents a highly attractive option for biologics production. However, several challenges remain to be addressed. Bacteria and yeast typically lack the cellular machinery necessary for processing complex biological structures. This limitation underscores the critical importance of selecting the most suitable production system for each target molecule. Moreover, a significant hurdle is the insufficient understanding of the expression systems and processes involved, which complicates the production of proteins that meet both quantity and quality requirements. Fortunately, as the industry continues to adopt more sensitive technologies, there is now an unprecedented opportunity to gain insights into product quality at earlier stages of development. This advancement allows for a more thorough understanding of how to achieve desired quality characteristics from the outset. However, it also necessitates more iterations during the development phase to ensure that these quality benchmarks are met early in the process.
Scaling microbial fermentation presents a host of challenges, particularly in the realms of process control, oxygen transfer, and heat management. These factors are crucial for optimizing growth conditions, especially for fast-growing bacterial cultures. To maximize growth rates, it is essential to ensure adequate oxygen transport throughout the cultivation system. This requirement necessitates effective mixing and appropriate airflow velocity. Insufficient oxygen can hinder microbial metabolism, ultimately impacting yield and productivity. Heat management is another critical aspect of microbial fermentation. Unlike cell cultures, microbial fermentation generates more heat, necessitating precise temperature control typically within ±1 or 2 °C. Excess heat must be efficiently dissipated by the equipment to prevent uncontrolled temperature spikes, which can pose significant challenges during large-scale production.
The use of antibiotics to select bacteria capable of maintaining high expression levels of the desired product introduces a unique set of challenges in bacterial fermentation. Post-treatment, it is imperative to remove these antibiotics, as regulatory bodies expect manufacturers to demonstrate their effective elimination. This is often accomplished by employing very low initial concentrations of specific antibiotics and verifying their removal through targeted analytical methods. Additionally, dilution effects observed during various purification steps can aid in this process. In response to these challenges, the development of host systems that do not rely on antibiotics while ensuring stable expression has become an important goal in the production of recombinant proteins and plasmids. This innovation not only enhances compliance with regulatory standards but also streamlines the production process. Increasing plasmid production poses another challenge; simply increasing the number of cells does not guarantee higher plasmid yields. The preservation of plasmids can adversely affect cell growth, necessitating a careful balance between optimizing plasmid yield and maintaining an adequate growth rate. Achieving this equilibrium can be complex and requires thoughtful optimization strategies.
One significant characteristic that influences the suitability of microbial fermentation for biopharmaceutical production is the glycosylation capability of specific microorganisms. For instance, Escherichia coli (E. coli) is limited in its ability to perform post-translational modifications, whereas yeast possesses the ability to glycosylate proteins, albeit not in the same manner as mammalian cells. The nature of the required post-translational modifications ultimately dictates the choice of host organism for production. While some modifications can be achieved through in vitro techniques, leveraging the cellular machinery of the host organism is generally preferred. This approach allows for a more natural and efficient production of biologics. Although optimizing process parameters may enhance outcomes, it cannot entirely substitute for the inherent capabilities of the chosen microorganism. Consequently, E. coli and yeast emerge as effective and complementary systems for producing biomolecules that do not necessitate human-like glycosylation.
In the realm of fermentation processes, real-time monitoring of production parameters has become an essential task for the biopharmaceutical industry. The integration of Process Analytical Technology (PAT) during fermentation allows for the identification of potentially problematic changes in real-time. This capability facilitates either manual or automated adjustments to maintain the process within a proven operating range. By employing PAT, manufacturers can enhance both the success and consistency of their fermentation processes. This proactive approach not only conserves time and resources but also upholds the highest quality standards throughout production.
Optimizing the process of microbial fermentation for protein production necessitates a careful consideration of the type of organism employed. In certain process designs, the host organism can efficiently secrete the protein into the fermentation medium, facilitating relatively straightforward extraction through tangential flow filtration (TFF) using hollow fiber membranes. In contrast, other processes, such as those involving Escherichia coli (E. coli), produce proteins within the cytoplasm, either as soluble proteins or as insoluble inclusion bodies. These varying production methods require tailored collection strategies that are specific to the product being generated. Proteins retained within the cytoplasm necessitate complete cell lysis, which can be achieved through mechanical methods like high-pressure homogenization. This approach effectively breaks open the cells to release the desired proteins into the surrounding medium. Conversely, proteins produced as insoluble inclusion bodies require additional procedures for unfolding and refolding to yield soluble, properly folded products. These extra steps not only complicate the overall process but also introduce the risk of contamination or potential damage to the final product.
In contrast, proteins produced as insoluble inclusion bodies necessitate intricate unwrapping and refolding procedures to yield soluble, properly folded products. These additional steps not only complicate the overall process but also risk introducing impurities or potentially damaging the final product.
Cell line engineering emerges as a promising strategy to tackle these challenges by focusing on enhancing the formation of correctly folded molecules within cells. However, this approach demands a tailored methodology for each specific product, which entails significant time and effort in selecting the appropriate host and developing the initial processes. To achieve optimal titers and yields, it is crucial to carefully choose the most suitable organism, expression system, operational sequence, and conditions right from the project’s inception.
The diversity of fermentation processes and the various molecules they produce complicate the creation of universal microbial fermentation platforms. Developing a versatile cell line and plasmid platform that can be effectively utilized for specific types of proteins or products would represent a significant advancement in addressing major challenges in fermentation. Moreover, adopting a platform-based approach for subsequent processing steps could aid in standardizing certain aspects of these production processes. While platform solutions for plasmid DNA production are gaining traction, these approaches still require flexibility to accommodate different plasmids and formats.
Another vital area of focus in the realm of microbial fermentation is the consistency among all parties involved. Regulatory authorities have established clear guidelines for developing fermentation processes that adhere to stringent quality requirements. This includes a comprehensive understanding of the system and its functionality, as well as the identification of the design space within which fermentation can occur.
A systematic approach is essential for the design and optimization of fermentation processes. This involves conducting experimental research to explore the interactions between cell lines and culture conditions, as well as their impact on product growth and yield. Much of the work related to process development and characterization can be effectively modeled using small fermenters in laboratory settings.
Aligning laboratory models with those used in manufacturing is crucial for fine-tuning processes and ensuring reliable performance at scale. However, maintaining consistency across various parameters can prove challenging, particularly for critical factors such as dissolved oxygen concentration. Therefore, careful consideration of the type of tank utilized is vital to optimizing consistency between models.
Matching small-scale and large-scale models enables researchers to investigate deviations from normal conditions, thereby accelerating the analysis of process consistency and variability while also reducing costs. Laboratory models serve as valuable tools for identifying raw materials and assessing the risk of variability throughout production cycles.
It is important to note that the optimization of fermentation reactions should not focus solely on yield; process reliability, consistency, and other critical attributes—including oxygen levels and oxygen transport—are equally important. The design of the fermentation process should take into account expected target yields and the ultimate goals of fermentation to prevent scalability issues.
